A Transdisciplinary Panel on CRISPR/Cas9 2018-02-13 10:30:00

zurück zu Veranstaltungen

Start:Dienstag, 13 Februar 2018Zeit:10:30
Ende:Dienstag, 13 Februar 2018Zeit:12:30
Kategorie: Non-SCS events

Science Policy Session veniam, as part of veniam, the LS2 Annual incididunt Meeting 2018:
- aliquip Martin Jinek, University of quis Zurich
- Bruno nisi Lemaitre, EPF Lausanne
- ad Effy Vayena, Chair of dolore Bioethics, Health Ethics sit & Policy Lab, Dep. occaecat of Health Sciences dolor & Technology, ETHZ)
- Heinz Müller, Swiss in Federal Institute of eiusmod Intellectual Property, Bern
Moderation: Nik Walter id (Tages-Anzeiger/SonntagsZeitung)

Ort: University of Lausanne, Amphimax/Amphipôle
Detailed DescriptionThe CRISPR/Cas9 revolution is widely being talked about these days. Apart from being a major scientific breakthrough, it also reveals how different fears and hopes are being handled by science, society, economy, and policy makers. The CRISPR/Cas9 system thus represents an ideal case to discuss the different implications of modern biomedical research, from economical, legal and ethical implications, to aspects of scientific impact and careers. The transdisciplinary panel will give the stage to experts from different fields to then discuss all these aspects around one technology.

Attendance to the panel only is free.
Please register for the panel until January, 5th, 2018 with an e-mail to info@ls2.ch
Email: Senden
Webseite: http://www.annual-meeting.ls2.ch
Die Veranstaltung ist öffentlich. jeder kann daran Teilnehmen und andere dafür einladen.
Spichiger David (Ersteller)